表紙
市場調査レポート

服薬遵守・患者関与(PACE):投資増額・新デジタルツール導入による、主な利害関係者の提携の実現と、服薬遵守の推進

Patient Adherence, Communication and Engagement (PACE) - Increased Investment and Adoption of New Digital Tools Enable Key Stakeholder Collaborations and Encourage Compliance

発行 GBI Research 商品コード 256251
出版日 ページ情報 英文 66 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
服薬遵守・患者関与(PACE):投資増額・新デジタルツール導入による、主な利害関係者の提携の実現と、服薬遵守の推進 Patient Adherence, Communication and Engagement (PACE) - Increased Investment and Adoption of New Digital Tools Enable Key Stakeholder Collaborations and Encourage Compliance
出版日: 2012年11月30日 ページ情報: 英文 66 Pages
概要

米国では現在、医療制度の最大の課題として、服薬遵守違反(Medication Non-adherence)に対する関心が高まっています。患者が指示通りの治療を行わない場合、医療の効率低下や医療施設の利用増加につながるからです。医療費は指数的に増加しており、医療費抑制・健康状態改善のために治療効率の改善が求められています。連邦政府の補助を受けて、医療用IT・技術の医療機関や保険会社などへの導入などが進み、また、情報システムや医療データの共有により、業界関係者の間での業務提携が可能となってきました。

当レポートでは、米国における服薬遵守・患者関与(PACE: Patient Adherence, Communication and Engagement)の推進に向けた取り組み(政策・事業提携など)について分析し、医療環境の概要と服薬遵守の促進要因、主な利害関係者(医薬品企業、医療機関など)への影響、ソーシャルメディア・キャンペーンの有効性、実現化手段としての各種技術の評価、成功事例の概要、有効な介入方法の開発といった事項を調査・考察して、その結果を概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

第3章 市場のダイナミクス

  • 服薬遵守違反に対する業界全体の関心の増大
  • 服薬遵守プログラムに対する投資を促進させるような、医療環境での主な傾向
    • 医療産業における変革促進要因
    • 新しい医療環境における機会と課題
    • 医療改革:アクセスの増加と成果の改善
    • 医療環境の優先事項の変化
    • HITECH:EHR(電子カルテ)の有意義な利用のための概説的基準
    • 米国保険福祉省(HHS)の医療データへの取り組み:医療変革の促進要因と見られている「接続可能なデータ」
  • 医薬品産業への影響
  • 今後の動向の見通し
    • 医療技術の傾向
    • 投薬・治療管理
    • ギヤ・シフト:mヘルスによるスマートフォン・個人デバイスの活用
    • ソーシャルメディアやオンライン・ネットワーキングの普及
    • ケアの継続性(Continuum of Care)を通じた、医療面での提携

第4章 事業提携の役割

  • 主な利害関係者の、服薬遵守に向けた取り組み
    • 医薬品産業の患者関与に向けた努力
    • 医療機関
    • 医療制度
  • 業務提携の成功事例
    • 従業員向け糖尿病プログラム:医療機関・製薬企業との提携による患者関与の獲得
    • 複数の利害関係者の提携による、コミュニティ全体での予防・疾病管理への取り組み
    • 医薬品メーカーと保険会社の提携:保険金請求データの新薬開発への活用
    • ソーシャルメディア上での合同キャンペーン:患者グループとの協力

第5章 実現手段としての技術

  • 服薬遵守のための医療用IT
    • 服薬遵守プログラムの監視・適合のためのEHRおよび医療データ
    • 患者を自己管理に参加させるためのツールとしてのPHR(個人医療記録)
    • 技術の統合:個人・家庭向け医療装置
    • 医師と患者のmヘルスへの関与
    • 医療機関・医薬品企業によるソーシャルメディア・キャンペーン
  • ケーススタディ:患者関与・服薬遵守にむけた取り組みで活用されている技術ソリューション
    • 服薬遵守のための介入(Adherence Interventions)のための、EHRからの既存データの活用
    • ソーシャルメディアを通じた、糖尿病コミュニティとの関与
    • 個人用デバイスによる、医療分野での患者関与の促進
    • 患者の自己管理を促進するための、技術のコンビネーションの活用
    • 家庭用医療機器で獲得したデータとEMR(電子カルテ)との統合

第6章 結論

  • 服薬遵守の成功にとって、提携活動は重要である
  • 服薬遵守の改善の実現手段としての技術

第7章 付録

図表一覧

目次
Product Code: GBIHC268MR

Summary

GBI Research, a leading business intelligence provider, has released its latest research, "Patient Adherence, Communication and Engagement (PACE) - Increased Investment and Adoption of New Digital Tools Enable Key Stakeholder Collaborations and Encourage Compliance". The report focuses on the US health system's efforts to improve patient engagement and medication adherence. Key topics of the report include reforms in the US healthcare industry, technology adoption, mobile and social media in healthcare, industry collaborations and examples of patient engagement and adherence interventions. There is a increasing focus on medication non-adherence as a critical challenge in the US healthcare system. When patients do not adhere to their prescribed medication or treatment regimen, it leads to reduced efficiency of treatment and increased utilization of care facilities. Healthcare expenditure is rising at an exponential rate, forcing the industry to focus on efficiencies in care delivery to control costs and improve health outcomes. Health insurance reforms and new payment and reimbursement models place emphasis on outcome-based performance measures. Rising healthcare costs have provided impetus to the health organizations to collaborate on their patient engagement interventions in an effort to control the epidemic of non-adherence. Federal stimulus has increased adoption of healthcare information technology by the providers, and payers are also increasingly adopting healthcare technology. The integration of information systems across care facilities gives greater access to data and enables collaboration between different players in the industry. Health industry players leverage these systems and use this increased access to data, in combination with other technologies, to improve their patient engagement efforts.

Scope

  • Key drivers in the healthcare landscape increasing health organizations' focus and efforts on adherence
  • Implications for industry stakeholders, pharmaceutical manufacturers, health plans and healthcare providers
  • Examples of collaborative efforts within key stakeholder groups
  • Analysis of the key technology trends within the healthcare industry
  • Examples of adherence interventions that leverage technology to achieve their goals

Reasons to buy

  • Understand how the changing healthcare landscape is influencing different stakeholder groups to focus on patient engagement
  • Understand how industry players are forging collaborations with other organizations in their adherence efforts
  • Explore the effectiveness of social media and mobile campaigns
  • Analyze existing healthcare technologies that support patient engagement efforts
  • Analyze existing engagement best practices in adherence efforts
  • Develop effective adherence interventions that leverage technology for patient outreach

Executive Summary

Healthcare Goes Digital as Patient Adherence is Boosted by Information Technologies

Rising healthcare costs and phenomenal waste in the US healthcare system is forcing health services and industry players to re-think how care is delivered, states a new report by healthcare experts GBI Research.

The new report* states that healthcare information technologies are being embraced as a way to engage patients and increase efficiency in the healthcare system, in a bid to counteract the huge costs imposed by chronic diseases.

National expenditure on healthcare in the US has surpassed 17% of Gross Domestic Product (GDP), with an aging population and changing lifestyles reflecting a growing prevalence of chronic diseases. Chronic disease healthcare costs dominate national medical expenditure, primarily due to complications resulting from patient non-adherence to treatment and medication regimens. Non-adherence is a major cause of waste in healthcare systems across the world among chronic disease patients.

Non-adherence to medication negatively affects the patient as well as the industry: the patient faces less effective treatment and increased risks of hospitalization, while struggling healthcare systems face pressure to improve patient outcomes and control costs, and the pharmaceutical industry suffers from lower prescription sales and less evidence demonstrating a drug's efficacy profile.

The engagement of patients in their own healthcare empowers them to make meaningful choices, and hence healthcare industry reforms in the US emphasize two central tenets of patient access and engagement, and coordinated care. Information and communication technologies are playing a significant role in this.

Federal stimulus is driving investments in Healthcare Information Technology (HIT), making huge amounts of data open to access, enabling data sharing and coordination in care delivery. The US Department of Health and Human Services (HHS) has mandated technology adoption by the healthcare providers, with innovation grants, incentives and penalties offered by the Health Information Technology for Economic and Clinical Health (HITECH) Act. Rapidly increasing cost burden is also forcing US health insurance providers to leverage technology and collaborations, driving the industry towards better patient engagement.

Large investments have been injected into Electronic Health Records (EHR) and other healthcare information technology systems that allow care professionals to access and share high amounts of data. There technologies also allow care providers to have better dialog with patients and engage them in managing their own health. Patients are also being targeted using other digital tools, as an increasing usage of mobile internet and social media platforms provide opportunities for engagement between patients and healthcare industry. As patients go online to seek health information and connect with support networks, there is an increased need for trusted sources for health information. Pharmaceutical companies are facilitating and participating in this online dialog to provide patients with authentic information and increasing patient engagement.

Technological advances have already demonstrated improved patient adherence, with electronic health records, e-prescribing, mHealth apps and social media campaigns all playing a part. Industry stakeholders are realizing the potential in collaborating to produce better care delivery and resource benefits, as technology and data-sharing promotes cross-industry collaborations, uniting pharmaceutical manufacturers, health insurance payers, pharmacies and employers, to build better patient engagement.

Patient Adherence, Communication and Engagement (PACE) - Increased Investment and Adoption of New Digital Tools Enable Key Stakeholder Collaborations and Encourage Compliance

This report focuses on the US health system's efforts to improve patient engagement and medication adherence. Key topics of the report include reforms in the US healthcare industry, technology adoption, mobile and social media in healthcare, industry collaborations and examples of patient engagement and adherence interventions.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GBI Research's team of industry experts.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Patient Adherence, Communication and Engagement (PACE) - Introduction

3. Patient Adherence, Communication and Engagement (PACE) - Market Dynamics

  • 3.1. Medication Non-adherence Gains Industry-wide Attention
  • 3.2. Key Trends in Healthcare Landscape Driving Investment in Adherence Programs
    • 3.2.1. Change Drivers in the Healthcare Industry
    • 3.2.2. Opportunities and Challenges in the New Healthcare Landscape
    • 3.2.3. Healthcare Reform - Increasing Access and Improving Outcomes
    • 3.2.4. Changing Priorities in Healthcare Landscape
    • 3.2.5. HITECH - Outlined Criteria for Meaningful Use of EHRs
    • 3.2.6. HHS Health Data Initiative - Accessible Data is Seen as a Change Driver in Healthcare
  • 3.3. Implications for Pharmaceutical Industry
  • 3.4. Trends Showing the Way Forward
    • 3.4.1. Healthcare Technology Trends
    • 3.4.2. Medication Therapy Management
    • 3.4.3. Shifting Gears - mHealth Leveraging Smart Phones and Personal Devices
    • 3.4.4. Rising Prominence of Social Media and Online Networking
    • 3.4.5. Healthcare Collaboration across Continuum of Care

4. Patient Adherence, Communication and Engagement (PACE) - Role of Collaborations

  • 4.1. Key Stakeholders in Patient Adherence and Engagement Initiatives
    • 4.1.1. Patient Engagement Efforts of Pharmaceutical Industry
    • 4.1.2. Healthcare Providers
    • 4.1.3. Health Plans
  • 4.2. Examples of Successful Industry Collaborations
    • 4.2.1. Employer Diabetes Program in Collaboration with Healthcare Providers and Drug Maker Achieves Patient Engagement
    • 4.2.2. Community-wide Preventive and Disease Management Initiative by Multiple Stakeholder Alliance
    • 4.2.3. Manufacturers Collaborate with Payers to Use Claims Data for New Drug Discovery
    • 4.2.4. Integrated Social Media Campaign in Partnership with Patient Groups

5. Patient Adherence, Communication and Engagement (PACE) - Technology as Enabler

  • 5.1. Healthcare IT in Promoting Adherence
    • 5.1.1. EHR and Health Data in Monitoring and Tailoring Adherence Programs
    • 5.1.2. PHR as a Tool to Engage Patients in Self-management
    • 5.1.3. Technology Integration - Personal and Home Health Devices
    • 5.1.4. Engaging Physicians and Patients with mHealth
    • 5.1.5. Social Media Campaigns by Health Organizations and Pharmaceuticals
  • 5.2. Case Studies - Technology Solutions Utilized in Engagement and Adherence Initiatives
    • 5.2.1. Leveraging Existing Data from EHR for Driving Adherence Interventions
    • 5.2.2. Engaging with the Diabetes Community through Social Media
    • 5.2.3. Personal Devices to Promote Patient Engagement in Healthcare
    • 5.2.4. Utilizing a Combination of Technologies for Engaging Patients in Self-management
    • 5.2.5. Integrating Data Captured by Home Health Devices with EMR

6. Patient Adherence, Communication and Engagement (PACE) - Conclusions

  • 6.1. Collaboration is Critical for Success in Adherence Initiatives
  • 6.2. Technology as an Enabler for Improving Adherence

7. Patient Adherence, Communication and Engagement (PACE) - Appendix

  • 7.1. Market Definition
  • 7.2. Abbreviations
  • 7.3. References
  • 7.4. Research Methodology
    • 7.4.1. Coverage
    • 7.4.2. Secondary Research
    • 7.4.3. Primary Research
    • 7.4.4. Expert Panel Validation
  • 7.5. Contact Us
  • 7.6. Disclaimer

List of Tables

  • Table 1: PACE Industry Drivers, Challenges and Opportunities, 2012
  • Table 2: PACE, % of Medicare FFS Beneficiaries, The US, by Number of Chronic Conditions and Age, 2008
  • Table 3: PACE, Distribution of Medicare FFS Beneficiaries, The US, by Number of Chronic Conditions and Healthcare Utilization, 2008
  • Table 4: PACE, Mean Expenses per Person with Healthcare Expenses, The US, by Service Type, ($) 2009
  • Table 5: PACE, Active Prescribers Using EHRs vs. Standalone E-prescribing Systems, The US, (%), 2008-2011
  • Table 6: PACE, Written Summaries Provided to Beneficiaries, The US, by % of MTM Programs, 2010-2011
  • Table 7: PACE, Beneficiary Interventions, The US, % of MTM Programs, 2010-2011
  • Table 8: PACE, Provider of MTM Services, The US, by % of MTM Programs, 2010-2011
  • Table 9: PACE, Subscriber Base per 100 Inhabitants, The US, by ICT Type, 2006-2011
  • Table 10: PACE, Social Media Presence, the US, by Hospital, 2012
  • Table 11: PACE, Diabetes Prevention Program, Program Outcomes, 2012
  • Table 12: PACE, Adult Asthma Prevalence, Michigan, by Age, 2008
  • Table 13: PACE, Michigan, Child Asthma Prevalence, by Age, 2008
  • Table 14: PACE, Diabetes Therapeutics Market, The US, Revenue ($bn), 2003-2010
  • Table 15: PACE, Diabetes Therapeutics Market, The US, Revenue Forecasts ($bn), 2010-2017
  • Table 16: PACE, Multi-channel Diabetes Campaign, Social Media Components, 2009-2012
  • Table 17: PACE, Multi-channel Diabetes Campaign, Social Media Performance, 2009-2012
  • Table 18: PACE, Adults with Diagnosed Diabetes, Georgia, % by Age, 2001-2010
  • Table 19: PACE, Diabetes Treatment Program, Technologies, 2008
  • Table 20: PACE, Hypertension Control Intervention, Technologies, 2012
  • Table 21: PACE, Hypertension Control Initiative, Technologies, 2012

List of Figures

  • Figure 1: PACE Industry Drivers, 2012
  • Figure 2: PACE, % of Medicare FFS Beneficiaries, The US, by Number of Chronic Conditions and Age, 2008
  • Figure 3: PACE, Distribution of Medicare FFS Beneficiaries, The US, by Number of Chronic Conditions and Healthcare Utilization, 2008
  • Figure 4: PACE, Mean Expenses per Person with Healthcare Expenses, The US, by Service Type, ($), 2009
  • Figure 5: PACE, National Health Spending, The US, by Sponsors, ($tn), 2010
  • Figure 6: PACE, Active Prescribers Using EHRs vs. Standalone E-prescribing Systems, The US, (%), 2008-2011
  • Figure 7: PACE, Written Summaries Provided to Beneficiaries, The US, by % of MTM Programs, 2010-2011
  • Figure 8: PACE, Beneficiary Interventions, The US, % of MTM Programs, 2010-2011
  • Figure 9: PACE, Provider of MTM Services, The US, by % of MTM Programs, 2010-2011
  • Figure 10: PACE, Subscriber Base per 100 Inhabitants, the US, by ICT Type, 2006-2011
  • Figure 11: PACE, FDA Guidelines on Responding to Unsolicited Information on Social Media, the US, 2011
  • Figure 12: PACE, Diabetes Care Program, Program Outcomes, 2007-2009
  • Figure 13: PACE, Pain Awareness Raising Initiative in Partnership with Patient Groups, Global, 2010
  • Figure 14: PACE, Adult Asthma Prevalence, Michigan, by Age, 2008
  • Figure 15: PACE, Child Asthma Prevalence, Michigan, by Age, 2008
  • Figure 16: PACE, Asthma Wellness Program, Program Outcomes, 2012
  • Figure 17: PACE, Diabetes Therapeutics Market, The US, Revenue Forecasts ($bn), 2003-2017
  • Figure 18: PACE, Adults With Diagnosed Diabetes, Georgia, % by Age, 2001-2010
  • Figure 19: PACE, Diabetes Treatment Program, Program Outcomes, 2008
  • Figure 20: PACE, Hypertension Control Initiative, Program Outcomes, 2012
Back to Top